Thanks for your research. I agree fully and your analysis is spot on. The Prospects are looking very very good. The question I have is when would an acquirer like Athenex enter into strategic partnership with a company like DCTH for a majority stake, on whose Board their Chief Strategy Officer sits. At the time when the price is still very very low, while the prospect from trial perspective looking very very high or whem the successful trial results are baked in pps? Logical answer is former i.e. now. All the results and reports are already in front of ATNX via Pedder. ATNX Equity financing is roughly 60M now complete and for a Company like ATNX that has over a billion dollar market cap, spending 10 to 20 Million to get a majority stake in DCTH is like spending loose change cor synergies mentioned earlier.
The other recent acquisitions by ATNX of QuaDPharma, Polymed Therapeutics, Comprehensive Drug Enterprises, to name a few, had somewhat similar process.
I have not seen anything so far contrary to my hypothesis.
We shall see the PR coming out latest by next week, if not today.
Good things come to those who wait.
Cheers!
News 
Market Data 
Discover 
